Related Experiment Videos
[Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results]
J L Wémeau1, C Cousty, V Vlaeminck
1Clinique Endocrinologique Marc Linquette, USNA, CHRU de Lille 6, rue du Pr Laguesse, 59 037 Lille cedex, France.
Annales D'Endocrinologie
|July 13, 2000
Summary
Thyroid hormone suppressive therapy can reduce thyroid nodule size. This study found levothyroxine treatment beneficial for solitary thyroid nodules, unlike placebo, with no observed side effects.
Area of Science:
- Endocrinology
- Thyroidology
- Oncology
Background:
- The efficacy of thyroid hormone therapy for thyroid nodules remains debated.
- Suppressive therapy's role in differentiating benign from malignant nodules is unclear.
Purpose of the Study:
- To prospectively evaluate the effect of levothyroxine suppressive therapy on solitary thyroid nodules.
- To assess the impact of suppressive therapy on ultrasonographically detected micronodular changes.
Main Methods:
- A prospective study involving 123 patients with solitary thyroid nodules.
- Comparison between levothyroxine suppressive therapy and placebo over 18 months.
- Ultrasonographic measurement of nodule volume and detection of micronodular dystrophy.
Main Results:
- Nodule volume significantly regressed from 2.76 to 2.39 ml in the levothyroxine group.
- Nodule volume increased from 3.6 to 4.1 ml in the placebo group.
- Suppressive therapy showed benefits in reducing micronodular dystrophy.
Conclusions:
- Levothyroxine suppressive therapy appears beneficial for reducing thyroid nodule size.
- The therapy was well-tolerated with no reported side effects.
- Preliminary findings support suppressive therapy's benefit, aligning with meta-analysis results.